News | March 25, 2011

Vital Images and Bayer HealthCare Diagnostics Arrange Collaboration

March 25, 2011 – The diagnostic imaging business unit of Bayer Vital GmbH and Vital Images, have signed a cooperation agreement. The agreement’s objective is to conduct joint activities that will introduce radiologists in Germany to the combination of appropriate software and contrast agents.

“Rapid developments in advanced visualization software used with state-of-the-art MRI and CT imaging techniques are delivering a huge amount of additional information,” said Robert Hite, head of the diagnostic imaging business in Germany. “This is presenting the evaluating radiologists with the challenge of efficiently selecting the right information from the constantly growing volume of image data. Both image processing software and contrast agents greatly assist diagnostic efficiency and when used in tandem could deliver substantial benefits for the evaluating radiologist. If we can coordinate the two techniques better, it could lead to considerable synergies to the benefit of the radiologist.”

“We are excited by our groundbreaking collaboration with Bayer in Germany and feel it will help grow our global business and development activities,” said Michael H. Carrel, CEO Vital Images. “This is a truly unique collaboration involving visualization with contrast agents and we are confident that, with Bayer, we have found the right partner to make this kind of collaboration a success.”

For more information: www.vitalimages.com

Related Content

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...